The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.
About VIVO ™ Catheter Precision’s VIVO (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, ...
Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac ...
Invasive epicardial coronary physiologic assessment is increasingly performed to evaluate the hemodynamic significance of ...
Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...
Giant omphalocoeles, defined by a defect larger than 5 cm or significant liver herniation, present unique challenges due to viscero-abdominal disproportion. Traditional staged closure techniques aim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results